Who
Jesse Shefferman
CEO and President
Company insider
Files Form 4 as: CEO and President, Protara Therapeutics.
In numbers
- Trades disclosed
- 58
- Buys
- 1
- Sells
- 1
- Bought
- $35K
- Sold
- $1.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Jan 2020
- Last trade
- 30 Jun 2026
- Last filed
- 1 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code G | —14,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code G | —7,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code G | —4,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code G | —14,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code G | —7,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code G | —4,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 29 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code M | $412K215,687 at $1.91 | filing |
| 29 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Sold | $882K215,687 at $4.09 | filing |
| 29 Jun 2026filed 1 Jul 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —215,687 at $0.00 | filing |
| 29 Jun 2026filed 1 Jul 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —215,687 at $0.00 | filing |
| 29 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code M | $412K215,687 at $1.91 | filing |
| 29 Jun 2026filed 1 Jul 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Sold | $882K215,687 at $4.09 | filing |
| 26 Jan 2026filed 27 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $58K8,732 at $6.67 | filing |
| 26 Jan 2026filed 27 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $58K8,732 at $6.67 | filing |
| 20 Jan 2026filed 22 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $91K16,322 at $5.60 | filing |
| 20 Jan 2026filed 22 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $91K16,322 at $5.60 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —87,000 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —524,000 at $0.00 | filing |
News
Protara Therapeutics (NASDAQ:TARA) Stock Price Down 5.3% – Here's WhyTARA · themarketsdaily.com · 15 Oct 2026
0 headlines in the last 90 days name Jesse Shefferman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.